✦ LIBER ✦

Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site

✍ Scribed by Hitoshi Kusaba; Yoshihiro Shibata; Shuji Arita; Hiroshi Ariyama; Eishi Baba; Kenji Mitsugi; Mine Harada; Shuji Nakano

Book ID: 110630477
Publisher: Springer US
Year: 2007
Tongue: English
Weight: 64 KB
Volume: 24
Category: Article
ISSN: 1357-0560
DOI: 10.1007/bf02698049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epirubicin, cisplatin, and prolonged or

Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil in the treatment of carcinoma of unknown primary site

✍ C. S. Karapetis; D. Yip; K. Virik; A. Strickland; K. Ryder; M. Cowling; P. G. Ha 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 83 KB

Gemcitabine and docetaxel as front-line

Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary site

✍ Damien Pouessel; Stéphane Culine; Catherine Becht; Marc Ychou; Gilles Romieu; Mi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

## Abstract ## BACKGROUND The current study was performed to evaluate the efficacy and toxicity of a noncisplatin‐based chemotherapy regimen combining gemcitabine and docetaxel as front‐line chemotherapy for patients with carcinoma of an unknown primary site. ## METHODS Patients were to receive

Gemcitabine and docetaxel as front-line

Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary site

✍ Alberto Muñoz; José Ramón Barceló; Guillermo López-Vivanco 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

tional RCC and extensively cystic Bosniak Grade 2 or 3 disease, which may be difficult to diagnose reliably using either fine-needle or core-needle biopsy. Correlation of the results presented by Volpe et al. with the additional findings discussed in the current correspondence may be useful.

Gemcitabine and cisplatin in patients wi

Gemcitabine and cisplatin in patients with carcinoma of unknown primary site

✍ Metin Isik; Mehmet M. Seker; Hatice Odabas; Fahriye T. Kos; Dogan Uncu; Nurullah 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 153 KB

Phase II study of cisplatin, 5-fluoroura

Phase II study of cisplatin, 5-fluorouracil and folinic acid in patients with carcinoma of unknown primary origin

✍ Raber, Martin N.; Frost, Philip; Schmidt, Susan; Abbruzzese, James L.; Lenzi, Re 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Docetaxel/cisplatin as first-line chemot

Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma : A Phase II trial

✍ Martina Baur; Heinz-Roland Kienzer; Johannes Schweiger; Maria DeSantis; Erich Ge 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this Phase II study was to assess the clinical activity and toxicity of docetaxel (D) and cisplatin (P) in patients with locally advanced unresectable, metastatic, or recurrent squamous cell carcinoma of the head and neck (SCCHN). ## PATIENTS Of 34 pati